By using LOX-RNAi-LV to transduce the MDA-MB-231 breast cancer cell line, researchers have observed a significant inhibition in the expression of MMP-2 and MMP-9, leading to reduced invasion and migration abilities of breast cancer cells 35. Here, LOX is linked to breast cancer.